Align Technology, Inc. (0HCK.L)
USD 167.1
(2.38%)
USD 167.1
(2.38%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 3.86 Billion USD | 3.42% |
| 2022 | 3.73 Billion USD | -5.51% |
| 2021 | 3.95 Billion USD | 59.9% |
| 2020 | 2.47 Billion USD | 2.71% |
| 2019 | 2.4 Billion USD | 22.39% |
| 2018 | 1.96 Billion USD | 33.47% |
| 2017 | 1.47 Billion USD | 36.44% |
| 2016 | 1.07 Billion USD | 27.72% |
| 2015 | 845.48 Million USD | 11.01% |
| 2014 | 761.65 Million USD | 15.37% |
| 2013 | 660.2 Million USD | 17.89% |
| 2012 | 560.04 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 977.87 Million USD | -4.92% |
| 2024 Q1 | 997.43 Million USD | 4.25% |
| 2024 Q2 | 1.02 Billion USD | 3.11% |
| 2023 Q4 | 956.72 Million USD | -0.36% |
| 2023 FY | 3.86 Billion USD | 3.42% |
| 2023 Q1 | 943.14 Million USD | 4.62% |
| 2023 Q2 | 1 Billion USD | 6.26% |
| 2023 Q3 | 960.21 Million USD | -4.19% |
| 2022 Q4 | 901.51 Million USD | 1.25% |
| 2022 Q3 | 890.34 Million USD | -8.17% |
| 2022 FY | 3.73 Billion USD | -5.51% |
| 2022 Q1 | 973.21 Million USD | -5.61% |
| 2022 Q2 | 969.55 Million USD | -0.38% |
| 2021 Q3 | 1.01 Billion USD | 0.5% |
| 2021 Q4 | 1.03 Billion USD | 1.5% |
| 2021 Q1 | 894.77 Million USD | 7.22% |
| 2021 Q2 | 1.01 Billion USD | 12.97% |
| 2021 FY | 3.95 Billion USD | 59.9% |
| 2020 Q1 | 550.96 Million USD | -15.21% |
| 2020 Q3 | 734.14 Million USD | 108.38% |
| 2020 FY | 2.47 Billion USD | 2.71% |
| 2020 Q4 | 834.52 Million USD | 13.67% |
| 2020 Q2 | 352.31 Million USD | -36.05% |
| 2019 FY | 2.4 Billion USD | 22.39% |
| 2019 Q4 | 649.78 Million USD | 6.99% |
| 2019 Q3 | 607.34 Million USD | 1.11% |
| 2019 Q1 | 548.97 Million USD | 2.8% |
| 2019 Q2 | 600.69 Million USD | 9.42% |
| 2018 Q2 | 490.25 Million USD | 12.21% |
| 2018 Q1 | 436.92 Million USD | 3.7% |
| 2018 FY | 1.96 Billion USD | 33.47% |
| 2018 Q4 | 534.02 Million USD | 5.69% |
| 2018 Q3 | 505.28 Million USD | 3.07% |
| 2017 Q4 | 421.32 Million USD | 9.36% |
| 2017 Q1 | 310.34 Million USD | 5.85% |
| 2017 FY | 1.47 Billion USD | 36.44% |
| 2017 Q2 | 356.48 Million USD | 14.87% |
| 2017 Q3 | 385.26 Million USD | 8.07% |
| 2016 Q2 | 269.36 Million USD | 12.84% |
| 2016 Q1 | 238.72 Million USD | 3.67% |
| 2016 Q3 | 278.58 Million USD | 3.43% |
| 2016 FY | 1.07 Billion USD | 27.72% |
| 2016 Q4 | 293.2 Million USD | 5.25% |
| 2015 Q2 | 209.48 Million USD | 5.76% |
| 2015 Q4 | 230.27 Million USD | 10.9% |
| 2015 FY | 845.48 Million USD | 11.01% |
| 2015 Q3 | 207.63 Million USD | -0.88% |
| 2015 Q1 | 198.08 Million USD | -0.26% |
| 2014 FY | 761.65 Million USD | 15.37% |
| 2014 Q2 | 192.53 Million USD | 6.58% |
| 2014 Q1 | 180.64 Million USD | 2.35% |
| 2014 Q4 | 198.6 Million USD | 4.59% |
| 2014 Q3 | 189.87 Million USD | -1.38% |
| 2013 Q2 | 162.02 Million USD | 7.96% |
| 2013 FY | 660.2 Million USD | 17.89% |
| 2013 Q1 | 150.08 Million USD | 5.07% |
| 2013 Q3 | 164.5 Million USD | 1.53% |
| 2013 Q4 | 176.49 Million USD | 7.29% |
| 2012 Q4 | 142.84 Million USD | 0.0% |
| 2012 FY | 560.04 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Phreesia, Inc. | 356.29 Million USD | -983.994% |
| Accuray Incorporated | 446.55 Million USD | -764.909% |
| Elevance Health Inc. | 171.34 Billion USD | 97.746% |
| AxoGen, Inc. | 159.01 Million USD | -2328.911% |
| Boston Scientific Corporation | 14.24 Billion USD | 72.877% |
| CVS Health Corporation | 357.77 Billion USD | 98.92% |
| Cardinal Health, Inc. | 226.82 Billion USD | 98.297% |
| Centene Corporation | 141.26 Billion USD | 97.266% |
| DaVita Inc. | 12.14 Billion USD | 68.186% |
| HCA Healthcare, Inc. | 64.96 Billion USD | 94.055% |
| Hologic, Inc. | 4.03 Billion USD | 4.169% |
| Humana Inc. | 106.37 Billion USD | 96.369% |
| IDEXX Laboratories, Inc. | 3.66 Billion USD | -5.499% |
| Laboratory Corporation of America Holdings | 12.16 Billion USD | 68.242% |
| Masimo Corporation | 2.04 Billion USD | -88.578% |
| McKesson Corporation | 308.95 Billion USD | 98.75% |
| Patterson Companies, Inc. | 6.56 Billion USD | 41.198% |
| Quest Diagnostics Incorporated | 9.25 Billion USD | 58.255% |
| ResMed Inc. | 4.68 Billion USD | 17.566% |
| Henry Schein, Inc. | 12.33 Billion USD | 68.699% |
| Teladoc Health, Inc. | 2.6 Billion USD | -48.411% |
| Universal Health Services, Inc. | 14.28 Billion USD | 72.957% |
| Veeva Systems Inc. | 2.36 Billion USD | -63.401% |
| Baxter International Inc. | 14.81 Billion USD | 73.927% |
| Becton, Dickinson and Company | 19.37 Billion USD | 80.063% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 45.786% |
| Danaher Corporation | 23.89 Billion USD | 83.833% |
| Stryker Corporation | 20.49 Billion USD | 81.158% |
| Medtronic plc | 32.36 Billion USD | 88.066% |